Wednesday, 08/04/2010
|
Statistical Risk Assessment for Chemical Substances
Koji Kanefuji, The Institute of Statistical Mathematics; Takayuki Fujii, The Institute of Statistical Mathematics; Masayuki Kageyama, The Institute of Statistical Mathematics ; Masashi Gamo, National Institute of Advanced Industrial Science and Technology; Hiroe Tsubaki, The Institute of Statistical Mathematics
|
Application of Methods for Assessing Risk-Benefit in Clinical Trials
Menghui Chen, Merck & Co., Inc.; Shailaja Suryawanshi, Merck & Co., Inc.
9:05 AM
|
The Value of Personalized, Predictive Risk-Assessment Tools for the Prevention of Chronic Diseases
Edward J. Moler, Tethys Bioscience, Inc.; Louis P. Garrison, University of Washington; Janice Kolberg, Tethys Bioscience, Inc.; Harald Rinde, BioBridge Strategies Switzerland; Sean D. Sullivan, University of Washington
9:35 AM
|
Benefit Risk Assessment Incorporating Time Component
Paulette Ceesay, Merck & Co., Inc.; Richard Entsuah, Merck & Co., Inc.
9:50 AM
|
|